While white and Hispanic individuals are being diagnosed with melanoma more frequently in recent years, Hispanic and black patients continue to have advanced skin cancer at diagnosis, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. Those findings were made by a team of researchers from the Sylvester Comprehensive Cancer Center at the University of Miami...
Cigarette smoking and alcohol consumption before a head and neck cancer diagnosis strongly predict the patient's future risk of death, according to previously published studies. Now, results of a new study show a similar effect among those who continued these habits after their cancer diagnosis.
Enrique A. Mesri, Ph.D., associate professor of microbiology and immunology at the Miller School and a member of the Viral Oncology Research Program at Sylvester Comprehensive Cancer Center, has been appointed to Argentina's Committee of Advisors for Scientific and Technological Cooperation in Foreign Countries.
Nearly 600 people filled the Moore Building in Miami’s Design District on Wednesday night, November 11, to celebrate survivorship and raise more than $250,000 for research at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. The fundraiser, “Designed For a Cure” centered around a dozen Sylvester patients escorting their doctors and nurses down the runway. As the evening wrapped up, every person was on their feet clapping and cheering the stories of survival that were highlighted during the evening.
The thank you meeting between 21-year-old cancer survivor Steven Guarin and veteran Miller School cancer researcher Eckhard Podack, M.D., Ph.D., lasted only 30 minutes, but was nearly two decades in the making. In the early '90s, Podack, Sylvester distinguished professor and chairman of microbiology and immunology, created the antibody that is a key component of SGN-35, a potential new drug that vanquished Steven's...
A two-year collaboration between gastroenterologists and radiation oncologists at UHealth -- University of Miami Health System has resulted in a new application of endoscopic ultrasound (EUS) that benefits prostate cancer patients. Afonso Ribeiro, M.D., associate professor of medicine in the Division of Gastroenterology, led the study which examined the feasibility and safety of using EUS to implant markers in prostate cancer patients needing targeted radiation therapy.
A team of researchers from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has been awarded a $4 million grant from the National Institutes of Health to study the effects of stress management in black women with breast cancer. The scientists want to develop innovative and effective ways to help underserved women as they navigate a difficult time in their lives.
A prominent researcher at the Sylvester Comprehensive Cancer Center at the Miller School, has taken another major step in understanding the mechanisms of the immune system. For the second year in a row, Glen N. Barber, Ph.D., professor of medicine and Eugenia J. Dodson Chair in Cancer Research, and Hiroki Ishikawa, Ph.D., a post-doctoral fellow, have published their findings in the prestigious journal Nature.
A team of researchers at the University of Miami Miller School of Medicine has confirmed trends that different Hispanic population groups have higher incidence rates of certain cancers and worse cancer outcomes if they live in the United States than they do if they live in their homelands. Overall, the Miller School team found the cancer risk increases 40 percent or more for Hispanics in the United States.
h4. After Years of Inequality, Survival Rates Now Equivalent to Those of Caucasians
Physician-scientists at the University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center have published new research indicating that racial disparities in treating a rare gastrointestinal cancer have been greatly reduced.
For some time, researchers have known that protein p27 is an important inhibitor of the cell division that spreads cancer. Understanding the full mechanism and extent of that role has taken much longer. Now, scientists at the Braman Family Breast Cancer Institute at the Sylvester Comprehensive Cancer Center have solved part of the puzzle, discovering that p27 can severely misbehave when in bad company.
Breast cancer researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have been awarded a prestigious Department of Defense Synergistic Idea Award, one of just 12 such grants in the United States. The $725,000 research grant over two years will allow Lisa Baumbach, Ph.D., associate professor of pediatrics at the Miller School, and Mark Pegram, M.D., professor of medicine and associate director for clinical and translational research at the Braman Family Breast Cancer Institute at Sylvester, to expand their work examining the genetic differences found in African-American breast cancer patients.
The Sylvester Comprehensive Cancer Center at the University of Miami has a powerful new ally in the fight against cancer. The work of State Senator Ted Deutch (D-Boca Raton) will help Sylvester pull in millions of dollars more through state-funded competitive cancer research grants for years to come.
Researchers at the University of Miami Miller School of Medicine have found that dramatic disparities in breast cancer outcomes continue to exist for African-American women, regardless of the age at which they are diagnosed, extent of the cancer, type of treatment or socioeconomic status.
The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted the tenth annual Zubrod Memorial Lecture and Cancer Research Poster Session on Friday, May 8, 2009. Bert O’Malley, M.D., professor and chairman of the Department of Molecular and Cellular Biology at Baylor College of Medicine in Houston, was this year’s guest lecturer.
The 20,000 member Papanicolaou Corps for Cancer Research today announced its annual gift to fund cancer research at the Sylvester Comprehensive Cancer Center. The check for $3 million was presented to W. Jarrard Goodwin, M.D., director of Sylvester at the University of Miami Miller School of Medicine, part of the University of Miami Health System, and Sylvester Board of Governors Chair Joan Scheiner.
Sylvester Comprehensive Cancer Center, part of UHealth—University of Miami Health System, today announced it is the first cancer-care program in the region enabling clinicians to accurately manage delivery of radiation to prostate cancer tumors through a new technology called the Calypso® 4D Localization System™.
The Papanicolaou Corps for Cancer Research drew a record number of people to its 9th Annual Walkathon & Health Affair on Saturday, March 28th. At least 3,000 participants poured onto the campus of Florida Atlantic University in Boca Raton for the Pap Corps’ signature event.
The Papanicolaou Corps for Cancer Research will hold its 9th Annual Walkathon & Health Fair on Saturday, March 28, on the campus of Florida Atlantic University in Boca Raton.
A new discovery by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine points the way to critically important treatment possibilities for patients with advanced prostate cancer in whom chemotherapy and hormone therapy have failed.
The University of Miami Miller School of Medicine and its Sylvester Comprehensive Cancer Center are saddened to report the untimely passing of a renowned researcher, physician, colleague and friend. William J. Harrington, Jr., M.D., professor of medicine in the Division of Hematology-Oncology at the Miller School, died from a cerebral hemorrhage on January 29 at the age of 54.
The annual Landon-American Association for Cancer Research Prizes took a big step forward this year in recognizing key cancer research by adding two new awards. The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted the Seventh Annual Landon-AACR Prize Lectures on Friday, January 23, during which four scientists were recognized for their research.
A team of international researchers, including Nobel laureate Andrew V. Schally, Ph.D., M.D.h.c., D.Sc.h.c., distinguished professor of pathology at the University of Miami Miller School of Medicine and distinguished medical research scientist in the Department of Veterans Affairs, has uncovered a surprising new activity of growth hormone-releasing hormone (GHRH), which could redirect future studies.